A group of 852 hospitals participating in the 340B drug discount program want HHS to appeal a recent federal court decision that would allow drug makers to restrict discounts on drugs that are dispensed through contract pharmacies. There are multiple active lawsuits, with conflicting decisions , over whether drug companies are allowed to restrict 340B discounts to one contract pharmacy for each 340B hospital. A growing number of drug makers are restricting the discounts in various ways, and the suits...
IDP Issue:
Inside Drug Pricing - 01/03/2022